Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „occur“
Suchtreffer
Begriffe & Kennungen
Accofil · 4.8 · The most serious adverse reactions that may occur during Filgrastim treatment include: anaphylactic reaction,
Eintrag öffnenAccofil · 4.8 · The most serious adverse reactions that may occur during Filgrastim treatment include: anaphylactic reaction,
Eintrag öffnenActelsar HCT · 4.8 · 31 class. Adverse reactions known to occur with each component given singly but which have not been seen in cl
Eintrag öffnenActelsar HCT · 4.8 · Adverse reactions reported in all clinical trials and occurring more frequently (p≤0.05) with telmisartan plus
Eintrag öffnenActelsar HCT · 4.8 · Adverse reactions reported in all clinical trials and occurring more frequently (p≤0.05) with telmisartan plus
Eintrag öffnenActelsar HCT · 4.8 · The most commonly reported adverse reaction is dizziness. Serious angioedema may occur rarely (≥1/10 000 to <1
Eintrag öffnenActelsar HCT · 4.8 · The most commonly reported adverse reaction is dizziness. Serious angioedema may occur rarely (≥1/10 000 to <1
Eintrag öffnenActraphane · 4.8 · 7 Hypoglycaemia The most frequently reported adverse reaction is hypoglycaemia. It may occur if the insulin do
Eintrag öffnenActraphane · 4.8 · Anaphylactic reactions The occurrence of generalised hypersensitivity reactions (including generalised skin ra
Eintrag öffnenActraphane · 4.8 · Anaphylactic reactions The occurrence of generalised hypersensitivity reactions (including generalised skin ra
Eintrag öffnenActraphane · 4.8 · Hypoglycaemia The most frequently reported adverse reaction is hypoglycaemia. It may occur if the insulin dose
Eintrag öffnenActrapid · 4.8 · Anaphylactic reactions The occurrence of generalised hypersensitivity reactions (including generalised skin ra
Eintrag öffnenActrapid · 4.8 · Hypoglycaemia The most frequently reported adverse reaction is hypoglycaemia. It may occur if the insulin dose
Eintrag öffnenAdcetris · 4.8 · In clinical trials treatment emergent neuropathy occurred in 57% of the population, peripheral motor neuropath
Eintrag öffnenAdcetris · 4.8 · In clinical trials, serious infections and opportunistic infections occurred in 10% of patients, sepsis or sep
Eintrag öffnenAdcetris · 4.8 · In patients receiving ADCETRIS combination therapy, serious adverse reactions occurred in 34% of patients. Ser
Eintrag öffnenAdcetris · 4.8 · In the clinical trial of ADCETRIS as combination therapy with AVD, treatment emergent neuropathy occurred in 6
Eintrag öffnenAdcetris · 4.8 · In the clinical trial of ADCETRIS as combination therapy with CHP, treatment emergent neuropathy occurred in 5
Eintrag öffnenAdcetris · 4.8 · Serious adverse drug reactions occurred in 12% of patients. The frequency of unique serious adverse drug react
Eintrag öffnenAdcetris · 4.8 · Serious adverse reactions occurred in 39.4% patients receiving BrECADD treatment, and 36.4% in patients who re
Eintrag öffnen